← back to search

Gilbert Verbeken

KU Leuven · BE
🔎 Find collaborators in Ecology · Infectious Diseases →
Search 5.9M scientists by topic, h-index, country & funding — free.
Area of research
Ecology · Infectious Diseases
Research interest
Research interests include Phage therapy, Bacteriophage, Antibiotics, Biology, Microbiology, and Medicine.
h-index
citations
1,909
works
12
NIH funding
primary concept
email

Recent publications

Personalized bacteriophage therapy outcomes for 100 consecutive cases: a multicentre, multinational, retrospective observational study
Nature Microbiology 2024cited by 369position: middledoi
The Magistral Phage
Viruses 2018cited by 324position: middledoi
Expert Opinion on Three Phage Therapy Related Topics: Bacterial Phage Resistance, Phage Training and Prophages in Bacterial Production Strains
Viruses 2018cited by 205position: middledoi
Quality and Safety Requirements for Sustainable Phage Therapy Products
Pharmaceutical Research 2015cited by 257position: middledoi
Experimental phage therapy of burn wound infection: difficult first steps.
PubMed 2014cited by 211position: middle
Characterization of Newly Isolated Lytic Bacteriophages Active against Acinetobacter baumannii
PLoS ONE 2014cited by 109position: middledoi
Call for a Dedicated European Legal Framework for Bacteriophage Therapy
Archivum Immunologiae et Therapiae Experimentalis 2014cited by 95position: firstdoi
Taking Bacteriophage Therapy Seriously: A Moral Argument
BioMed Research International 2014cited by 52position: firstdoi
Business oriented EU human cell and tissue product legislation will adversely impact Member States’ health care systems
Cell and Tissue Banking 2013cited by 51position: lastdoi
Introducing yesterday‘s phage Therapy in today‘s Medicine
Future Virology 2012cited by 92position: middledoi
Optimizing the European Regulatory Framework for Sustainable Bacteriophage Therapy in Human Medicine
Archivum Immunologiae et Therapiae Experimentalis 2012cited by 87position: firstdoi
Selection and Characterization of a Candidate Therapeutic Bacteriophage That Lyses the Escherichia coli O104:H4 Strain from the 2011 Outbreak in Germany
PLoS ONE 2012cited by 57position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Jean‐Paul Pirnay · Queen Astrid Military Hospital10 papers (2012–2018) · 9 papers (2012–2018)Isabelle Huys · KU Leuven7 papers (2012–2018)Rob Lavigne · KU Leuven6 papers (2012–2014)Serge Jennes · KU Leuven6 papers (2012–2014) · 4 papers (2012–2014) · 4 papers (2012–2018)Ніна Чанішвілі · George Eliava Institute of Bacteriophage, Microbiology and Virology3 papers (2012–2018) · 3 papers (2012–2014) · 2 papers (2013–2014) · 2 papers (2012–2014) · 2 papers (2012–2014) · 2 papers (2014–2018)Dieter Vandenheuvel · KU Leuven2 papers (2012–2014) · 2 papers (2012–2014)Minne Casteels · KU Leuven2 papers (2012–2014) · 1 papers (2018–2018)Grégory Resch · University of Lausanne1 papers (2018–2018)Ronen Hazan · Hebrew University of Jerusalem1 papers (2018–2018) · 1 papers (2013–2013)
Looking for a research collaborator?
Search millions of scientists by field, institution, impact, and funding status — see their work, find their email, and reach out directly.
Find collaborators in Ecology · Infectious Diseases →